Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial

PURPOSE: A phase II, open-label, dose-finding, randomized study was performed to evaluate the recommended dose of pegfilgrastim in Japanese breast cancer patients. METHODS: Patients received 1.8, 3.6, or 6.0 mg of pegfilgrastim once per chemotherapy cycle for up to 6 cycles. Patients received doceta...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Support Care Cancer
Hoofdauteurs: Masuda, Norikazu, Tokuda, Yutaka, Nakamura, Seigo, Shimazaki, Ryutaro, Ito, Yoshinori, Tamura, Kazuo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2015
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552775/
https://ncbi.nlm.nih.gov/pubmed/25733000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-015-2654-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items